A potential role for insulin resistance in experimental pulmonary hypertension Source: Eur Respir J 2013; 41: 861-871 Year: 2013
Insulin therapy increases airway responsiveness in type 2 diabetes patients Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Characterizing the effects of inhaled human insulin (Exubera®) on FEV1 using disease progression modeling Source: Eur Respir J 2006; 28: Suppl. 50, 614s Year: 2006
Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019 Year: 2020
Pulmonary function test changes after cessation of inhaled corticosteroid therapy in asthma patients Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012
Changes in airway inflammation, remodelling and PD20 following inhaled corticosteroid treatment are not temporally concordant Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001
Hyperinsulinemia due to altered insulin secretion contributes to insulin resistance in chronic intermittent hypoxia independently of obesity Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing Year: 2019
Effect of discontinuation and readministration of inhaled human insulin on pulmonary safety in adult diabetes patients Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005
FEV1 response to albuterol is not affected by inhaled human insulin (Exubera®) use in subjects with mild-to-moderate asthma Source: Eur Respir J 2006; 28: Suppl. 50, 840s Year: 2006
The cell haemostasis changes under the glucocorticoid therapy influence in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 230s Year: 2006
Evaluating the effects of inhaled corticosteroid on insulin sensitivity in asthmatic patients Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016
Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007
Changes in glucose metabolism during treatment with high doses of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 502s Year: 2004
Early ICS treatment in subjects with a rapid decline in lung function Source: Eur Respir J 2001; 18: Suppl. 33, 348s Year: 2001
Reduced bone density in inhaled corticosteroids-treated asthmatic patients showing decreased cortisol response to low-dose ACTH test Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2 -agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007